Literature DB >> 3872604

Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.

E Koss, R P Friedland, B A Ober, W J Jagust.   

Abstract

Positron emission tomography with [18F]fluorodeoxyglucose revealed greater right than left hemispheric impairment of cortical glucose metabolism in patients with probable Alzheimer's disease who were younger than 65 but not in those over 65. This asymmetry was related to poor visuospatial performance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872604     DOI: 10.1176/ajp.142.5.638

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  19 in total

1.  Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients.

Authors:  Grégoria Kalpouzos; Francis Eustache; Vincent de la Sayette; Fausto Viader; Gaël Chételat; Béatrice Desgranges
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

2.  Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study.

Authors:  Yong Fan; Susan M Resnick; Xiaoying Wu; Christos Davatzikos
Journal:  Neuroimage       Date:  2008-03-06       Impact factor: 6.556

Review 3.  Roles of AMP-activated protein kinase in Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Keshen Li; Sohel H Quazi; Bin Zhao
Journal:  Neuromolecular Med       Date:  2012-02-26       Impact factor: 3.843

4.  Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.

Authors:  Roger L Albin; Robert A Koeppe; James F Burke; Bruno Giordani; Michael R Kilbourn; Sid Gilman; Kirk A Frey
Journal:  Arch Neurol       Date:  2010-04

5.  The investigation of Alzheimer's disease with single photon emission tomography.

Authors:  A Burns; M P Philpot; D C Costa; P J Ell; R Levy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

6.  Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.

Authors:  S Yamaguchi; K Meguro; M Itoh; C Hayasaka; M Shimada; H Yamazaki; A Yamadori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

Review 7.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

8.  Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia.

Authors:  K Meguro; C Doi; M Ueda; T Yamaguchi; H Matsui; S Kinomura; M Itoh; K Yamada; H Sasaki
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

9.  The lateralized smell test for detecting Alzheimer's disease: failure to replicate.

Authors:  Richard L Doty; Edgardo A Bayona; Daniel S Leon-Ariza; Juan Cuadros; Inna Chung; Britney Vazquez; Fidias E Leon-Sarmiento
Journal:  J Neurol Sci       Date:  2014-03-19       Impact factor: 3.181

10.  A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease.

Authors:  J T O'Brien; S Eagger; G M Syed; B J Sahakian; R Levy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.